Establishes bipartisan task force to study response to COVID-19 in New Jersey.
Impact
The main duty of the task force is to assess New Jersey's public health response to COVID-19. They will evaluate the effectiveness of intergovernmental communication and coordination during the pandemic, review the impact of the state’s measures on various demographics—including nursing home residents and children—and analyze financial repercussions for businesses and the state as a whole. Furthermore, the task force is also tasked with comparing New Jersey's COVID-19 statistics with those of other states that employed differing response strategies.
Summary
Assembly Bill A159 establishes a bipartisan task force in New Jersey to study the state's response to COVID-19. This task force will consist of eight members appointed by the President of the Senate, the Minority Leader of the Senate, the Speaker of the General Assembly, and the Minority Leader of the General Assembly. The bill mandates that the task force convene its first meeting within 45 days of the act's effective date, where they will elect a chairperson and vice-chairperson. The members will serve without compensation but can receive reimbursements for certain expenses incurred in their official duties.
Contention
As the task force is expected to conduct at least three public hearings across different state locations, it will gather public testimonies to inform its assessment. This participatory approach aims to ensure that the recommendations derived from their findings will consider diverse stakeholder perspectives. Once the task force concludes its review and compiles findings, they are required to report to the Governor and the Legislature within 18 months, after which the task force will dissolve. This legislative measure aims not only to evaluate past actions but also to enhance preparedness for future public health emergencies.